← Eichor
Condition: Hiv Pre Exposure Prophylaxis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv Pre Exposure Prophylaxis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Phase 4 · 3 location(s) · University of Witwatersrand, South Africa · NCT06485154Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06558825LA PrEP Impact and Cost-effectiveness (TEAMS)
NA · 12 location(s) · Institute of HIV Research and Innovation Foundation, Thailan · NCT05774548Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
NA · 4 location(s) · Public Health Foundation Enterprises, Inc. · NCT04855773Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships
NA · 1 location(s) · University of Pennsylvania · NCT07246057Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico
NA · 1 location(s) · University of Puerto Rico · NCT05804461Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NA · 8 location(s) · Universitair Ziekenhuis Brussel · NCT07029152HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Phase 4 · 6 location(s) · Cara Spence · NCT07160075A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06703060HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06919419Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention
NA · 1 location(s) · University of Stellenbosch · NCT06370923Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Phase N/A · 31 location(s) · Gilead Sciences · NCT07473778Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06158607The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Phase 3 · 1 location(s) · Evandro Chagas National Institute of Infectious Disease · NCT05515770Pre-exposure Prophylaxis (PrEP) for Health
NA · 2 location(s) · Brown University · NCT04430257HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
NA · 1 location(s) · University of Washington · NCT07089966A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Phase 4 · 1 location(s) · University of Connecticut · NCT05669534Universal Test and Connect for HIV Service Delivery in South Africa
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06408142The SwissPrEPared Study
Phase N/A · 41 location(s) · University of Zurich · NCT03893188Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT
Phase 3 · 1 location(s) · Africa Health Research Institute · NCT06250504Finishing HIV Project
NA · 1 location(s) · University of Miami · NCT06406049Point of Care STI Testing
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06844045Prevention ICONA Dedicated Ensemble
Phase N/A · 53 location(s) · Fondazione ICONA · NCT07186244Case Management Dyad
NA · 1 location(s) · University of Chicago · NCT06162897Vienna HIV Infection Via Sex Study
Phase N/A · 1 location(s) · Medical University of Vienna · NCT05326061A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297Thailand HIV and Stigma Reduction Study
NA · 3 location(s) · University of Massachusetts, Worcester · NCT06576648PathToScale: The PERSIST Trial
NA · 1 location(s) · Georgetown University · NCT07221747Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of
Phase 3 · 34 location(s) · ViiV Healthcare · NCT06134362
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.